• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

任务很重要——挑战运动系统可以将未受影响的 Parkin 基因突变携带者与无突变对照区分开来。

Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.

机构信息

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany; Department of Neurology, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy.

出版信息

Parkinsonism Relat Disord. 2021 May;86:101-104. doi: 10.1016/j.parkreldis.2021.03.028. Epub 2021 Apr 20.

DOI:10.1016/j.parkreldis.2021.03.028
PMID:33895538
Abstract

BACKGROUND

Heterozygous carriers of Parkin mutations are suggested to be at risk of developing Parkinson's disease, while biallelic variants are associated with typical autosomal recessive early-onset PD. Investigating unaffected heterozygous mutation carriers holds the potential of a deeper understanding of monogenic PD and has implications for PD in general, in particular regarding the prodromal phase.

OBJECTIVES

To discriminate healthy Parkin mutation carriers from healthy non-mutation carriers using a multimodal approach.

METHODS

Twenty-seven healthy heterozygous Parkin mutation carriers (13 female. age: 48 ± 13 years) and 24 healthy non-mutation carriers (14 female. age: 48 ± 15 years) from the CHRIS study (Cooperative Health Research in South Tyrol) were recalled based on their genetic profile and underwent a blinded assessment of motor and non-motor PD symptoms, transcranial sonography and sensor-based posturography and gait analyses under different conditions with increasing difficulty. For the latter, gradient-boosted trees were used to discriminate between carriers and non-carriers. The classification accuracy and the area under the curve of the receiver-operator characteristics curve were calculated.

RESULTS

We observed no differences concerning motor or non-motor symptoms and substantia nigra hyperechogenicity. The best gradient-boosted trees-based model on posturography measurements (tandem feet, eyes closed, firm surface), however, showed a classification accuracy of up to 86%. The best-performing gradient-boosted trees-based model for gait analyses showed a balanced accuracy of up to 87% (dual-tasking).

CONCLUSIONS

Sensor-based quantification of movements allows to discriminate unaffected heterozygous mutation carriers from mutation-free controls. Thereby, it is crucial to challenge the motor system with more difficult tasks to unmask subtle motor alterations.

摘要

背景

杂合子 Parkin 突变携带者被认为有患帕金森病的风险,而纯合子变体则与典型的常染色体隐性早发性 PD 相关。研究未受影响的杂合子突变携带者有可能更深入地了解单基因 PD,并对一般 PD 产生影响,特别是在前驱期。

目的

使用多模态方法区分健康的 Parkin 突变携带者和健康的非突变携带者。

方法

根据基因谱,从 CHRIS 研究(南蒂罗尔合作健康研究)中召回了 27 名健康的杂合子 Parkin 突变携带者(13 名女性,年龄:48 ± 13 岁)和 24 名健康的非突变携带者(14 名女性,年龄:48 ± 15 岁),并对他们进行了运动和非运动 PD 症状、经颅超声和基于传感器的姿势和步态分析的盲评,测试条件逐渐增加难度。对于后者,使用梯度提升树来区分携带者和非携带者。计算分类准确性和接收器操作特性曲线的曲线下面积。

结果

我们观察到携带者和非携带者在运动或非运动症状和黑质回声强度方面没有差异。然而,基于姿势测量(双脚并拢、闭眼、坚固表面)的最佳梯度提升树模型的分类准确性高达 86%。对于步态分析,表现最好的梯度提升树模型的平衡准确性高达 87%(双重任务)。

结论

基于传感器的运动量化可区分未受影响的杂合子突变携带者和无突变对照者。因此,通过更困难的任务来挑战运动系统以揭示细微的运动改变至关重要。

相似文献

1
Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.任务很重要——挑战运动系统可以将未受影响的 Parkin 基因突变携带者与无突变对照区分开来。
Parkinsonism Relat Disord. 2021 May;86:101-104. doi: 10.1016/j.parkreldis.2021.03.028. Epub 2021 Apr 20.
2
Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.一组早发性帕金森病患者中帕金单杂合子和复合杂合子的嗅觉功能
Acta Neurol Scand. 2016 Oct;134(4):271-6. doi: 10.1111/ane.12538. Epub 2015 Dec 1.
3
Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles.黑质高回声与临床状态及帕金突变等位基因数量相关。
J Neurol. 2007 Oct;254(10):1407-13. doi: 10.1007/s00415-007-0567-y. Epub 2007 Oct 15.
4
Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.巴西东北部一个遗传隔离群体中由新型帕金基因突变引起的早发性帕金森病。
Neurogenetics. 2006 Mar;7(1):13-9. doi: 10.1007/s10048-005-0017-x. Epub 2005 Nov 22.
5
Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.一个有77名帕金基因突变携带者的大家族中的路易体帕金森病。
Ann Neurol. 2005 Sep;58(3):411-22. doi: 10.1002/ana.20587.
6
Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers.健康受试者中杂合型帕金基因突变的频率:对突变携带者进行仔细的前瞻性随访检查的必要性。
Parkinsonism Relat Disord. 2009 Jul;15(6):425-9. doi: 10.1016/j.parkreldis.2008.11.014. Epub 2009 Jan 21.
7
Influence of L-dopa on subtle motor signs in heterozygous Parkin- and PINK1 mutation carriers.L-dopa 对杂合子 Parkin 和 PINK1 突变携带者细微运动体征的影响。
Parkinsonism Relat Disord. 2017 Sep;42:95-99. doi: 10.1016/j.parkreldis.2017.07.003. Epub 2017 Jul 8.
8
Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.富亮氨酸重复激酶 2 相关帕金森病及无症状突变携带者的临床和脑影像特征。
Mov Disord. 2011 Nov;26(13):2335-42. doi: 10.1002/mds.23991. Epub 2011 Oct 11.
9
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.早发性帕金森病中帕金基因突变的预测因素:早发性帕金森病风险联盟研究
Arch Neurol. 2010 Jun;67(6):731-8. doi: 10.1001/archneurol.2010.95.
10
Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.帕金森病的临床前代偿的映射:一种影像基因组学方法。
Mov Disord. 2009;24 Suppl 2:S703-10. doi: 10.1002/mds.22635.

引用本文的文献

1
Digital gait biomarkers in Parkinson's disease: susceptibility/risk, progression, response to exercise, and prognosis.帕金森病中的数字步态生物标志物:易感性/风险、疾病进展、运动反应及预后
NPJ Parkinsons Dis. 2025 Mar 21;11(1):51. doi: 10.1038/s41531-025-00897-1.
2
How to communicate and what to disclose to participants in a recall-by-genotype research approach: a multistep empirical study.如何在基于基因型的召回研究方法中与参与者进行沟通以及披露哪些信息:一项多步骤实证研究。
J Community Genet. 2024 Dec;15(6):615-630. doi: 10.1007/s12687-024-00733-8. Epub 2024 Sep 26.
3
Diverse Functions of Parkin in Midbrain Dopaminergic Neurons.
Parkin 在中脑多巴胺能神经元中的多种功能。
Mov Disord. 2024 Aug;39(8):1282-1288. doi: 10.1002/mds.29890. Epub 2024 Jun 10.
4
Parkinson's disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons.帕金森病相关的 parkin 突变破坏了人多巴胺能神经元中突触囊泡的再循环。
Neuron. 2023 Dec 6;111(23):3775-3788.e7. doi: 10.1016/j.neuron.2023.08.018. Epub 2023 Sep 15.
5
Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers.临床无症状杂合PRKN变异携带者线粒体功能障碍的分子表型
NPJ Parkinsons Dis. 2023 Apr 18;9(1):65. doi: 10.1038/s41531-023-00499-9.
6
Participant perspective on the recall-by-genotype research approach: a mixed-method embedded study with participants of the CHRIS study.参与者对基于基因型召回研究方法的看法:一项采用 CHRIS 研究参与者的混合方法嵌入式研究。
Eur J Hum Genet. 2023 Nov;31(11):1218-1227. doi: 10.1038/s41431-022-01277-6. Epub 2023 Jan 4.
7
Ten years of dynamic consent in the CHRIS study: informed consent as a dynamic process.CHRIS 研究中的十年动态同意:知情同意作为一个动态过程。
Eur J Hum Genet. 2022 Dec;30(12):1391-1397. doi: 10.1038/s41431-022-01160-4. Epub 2022 Sep 5.
8
Frequency of Heterozygous Parkin () Variants and Penetrance of Parkinson's Disease Risk Markers in the Population-Based CHRIS Cohort.基于人群的CHRIS队列中杂合型帕金()变体的频率及帕金森病风险标志物的外显率
Front Neurol. 2021 Aug 9;12:706145. doi: 10.3389/fneur.2021.706145. eCollection 2021.